A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance.
一种新型双有效载荷 ADC 平台,整合了依沙替康和雷公藤内酯,以增强抗肿瘤疗效并克服耐药性。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-25-0271
Ren Pengfei, Guan Menglong, Tang Jiao, Yin Shijun, Qi Lu, Yue Ju, Li Zhengping, Fan Xinzou, Lei Gang, Zuo Teng, Chen Jiao, Xu Yanhua, Ke Xiao, Zhao Yonghao